Navigation Links
Albemarle Reports Record Quarterly Net Sales and Operating Results
Date:4/21/2008

d government regulation of our operations or our products. Additional factors that could cause our results to differ materially from those described in the forward-looking statements can be found under "Risk Factors" in Item 1A of our Annual Report on Form 10-K for the period ended December 31, 2007 and in our other public filings with the Securities and Exchange Commission. Readers are urged to review and consider carefully the disclosures we make in our filings with the Securities and Exchange Commission.

Albemarle Corporation and Subsidiaries

Consolidated Statements of Income

(In Thousands of Dollars, Except Share and Per Share Amounts) (Unaudited)

First Quarter Ended

March 31,

2008 2007

Net sales $668,177 $589,238

Cost of goods sold 500,766 429,449

Gross profit 167,411 159,789

Selling, general and administrative expenses 63,519 62,486

Research and development expenses 16,800 15,711

Severance charges 3,278(a) -

Operating profit 83,814 81,592

Interest and financing expenses (10,216) (8,910)

Other income, net 2,846 952

Income before income tax expense, minority

interests and equity in net income of

unconsolidated investments 76,444 73,634

Income tax expense (16,626) (16,936)

Income before minority interests and equity

in net income of unconsolidated investments 59,818
'/>"/>

SOURCE Albemarle Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Albemarle Corporations First Quarter 2008 Earnings Conference Call To Be Held April 22, 2008 at 8:00am ET
2. Albemarle Corporations First Quarter 2008 Earnings Conference Call To Be Held April 22, 2008 at 9:00am ET
3. Albemarle Raises Prices of Specialty Aluminas
4. Albemarle to Raise Prices of Dibromomethane
5. Albemarle Reports Third Quarter 2007 Results
6. Albemarle to Increase Price of Ibuprofen
7. Quest Diagnostics Reports Strong Revenue and Earnings Growth in First Quarter 2008
8. Amylin Pharmaceuticals Reports First Quarter Financial Results
9. QMed, Inc. Reports First Quarter Results
10. TeamStaff, Inc. Reports Preliminary Second Quarter 2008 Results
11. Bioniche Reports the Passing of its Board Chair
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... June 19, 2013 Daily Gossip issued a ... training method will be published on their website at ... the article to inform readers about the information they will ... by reporters working at Daily Gossip, the article is a ... , Hiller has understood during the vast research he ...
(Date:6/19/2013)... June 19, 2013 Researchers from the ... demonstrated several new studies at ENDO 2013, The ... June 15-18 in San Francisco.     , Mount Sinai researchers ... the role of prostastic acid phosphatase (PAP) in Prostate ... stimulate the thyroid gland; revealed the prevalence of primary ...
(Date:6/19/2013)... Texas (PRWEB) June 19, 2013 ... today announced its intent to purchase privately ... Florida, a leader in wheelchair accessible vehicle sales, ... of Auto Mobility Sales, Inc compliments and expands ... wheelchair accessible mobility dealers . The acquisition ...
(Date:6/19/2013)... CCA , America's leader in ... to Vice President, Health Services, effective June 8, 2013. ... Services for CCA. He will replace the retiring ... privilege to lead CCA's dedicated team of health care ... society and our partners as we provide effective care ...
(Date:6/19/2013)... Carlsbad, CA (PRWEB) June 19, 2013 ... , DHSc, DC, MS, explains why such seemingly minor ... anxiety, or concussions are vital red flags. They indicate ... risk for multiple sclerosis (MS), Alzheimer’s, Parkinson’s, stroke, and ... , released in June 2013 by Elephant Press is ...
Breaking Medicine News(10 mins):Health News:The Jump Manual Review: Reveals Hiller’s Method of Vertical Jump Training 2Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 2Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 3Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 4Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 5Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 6Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 7Health News:HASCO Medical, Inc. to Acquire Auto Mobility Sales, Inc. 2Health News:CCA Names Dr. John Baxter Vice President, Health Services 2Health News:Brain Not Working? Minor Symptoms Now Could Mean MS, Alzheimer's, or Parkinson's Later 2Health News:Brain Not Working? Minor Symptoms Now Could Mean MS, Alzheimer's, or Parkinson's Later 3
... French . , Montreal, March 11, 2009 ... influence of cannabis (DUIC) and engage in reckless driving, according ... the journal Accident Analysis and Prevention , men who ... consider taking the wheel after consuming cannabis more often than ...
... 11 On Friday, March 6, 2009, Coast ... Justice, the FBI, the FDA, and the Commonwealth of Virginia ... Independent Review Board discovered that a protocol submitted for review ... of Clifton, Virginia, was fraudulent in violation of federal and ...
... most progressive benefit management firms, today announced a strategic partnership with ... will enable CBCA to provide an unparalleled suite of proven care ... ... OH (Vocus) March 11, 2009 -- CBCA Administrators, Inc. (CBCA), one ...
... LOS ANGELES, March 11 MMR Information ... through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. ... Records ("PHRs") ( www.mymedicalrecords.com ) and electronic ... ), announced that it has selected Gene ...
... March 11 The U.S. Agency for ... in Southern Africa launched a new program to reduce ... and Mpumalanga Provinces. The three-year, $5.1 million project is ... Relief (PEPFAR), and administered by USAID . A ...
... researchers wanted to know whether an increased CO2 ... therefore examined freshwater micro-algae: small, floating and mostly ... tanks called limnotrons. These were aerated with ordinary ... of CO2. The researchers then examined the ratio ...
Cached Medicine News:Health News:Study finds cannabis use, dangerous driving behaviors interrelated 2Health News:Clinical Trial Fraud Exposed by Coast IRB 2Health News:CBCA Administrators, Inc. Announces Strategic Partnership with KePRO 2Health News:CBCA Administrators, Inc. Announces Strategic Partnership with KePRO 3Health News:MMR Information Systems, Inc. Taps Health Information Technology Veteran Gene Barduson 2Health News:MMR Information Systems, Inc. Taps Health Information Technology Veteran Gene Barduson 3Health News:MMR Information Systems, Inc. Taps Health Information Technology Veteran Gene Barduson 4Health News:MMR Information Systems, Inc. Taps Health Information Technology Veteran Gene Barduson 5Health News:USAID and IOM Announce HIV Prevention and Care for Farm Workers 2
(Date:6/19/2013)... Israel , June 19, 2013 ... a phase I study in volunteers, and preliminary results ... of ND0612, were presented at the 2013 International Congress ... proprietary levodopa/carbidopa liquid drug formula under development for continuous ... maintain constant levodopa plasma concentrations. ND0612 has ...
(Date:6/19/2013)...   Life Technologies Corporation (NASDAQ: ... Suzhou Ribo Life Sciences (Ribo) the exclusive rights ... China using Life,s Invivofectamine® Rx ... in combination with Invivofectamine® Rx to create a ... high unmet medical need in the Chinese healthcare ...
(Date:6/19/2013)... Juni 2013 Specialty Coating ... Entwicklung von SCS microRESIST™, einer antimikrobiellen ... Beschichtung mit Parylene gelungen ist. SCS ... Parylene mit antimikrobiellen Eigenschaften und erlaubt ... auf beschichteten medizinischen Geräten. ...
Breaking Medicine Technology:NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 2NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 3NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 4NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 5NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 6Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 2Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 4Specialty Coating Systems gibt die Einführung einer neuen antimikrobiellen Parylene-Technologie bekannt 2
... TARRYTOWN, N.Y. and BERLIN, April 8, 2011 ... and Bayer HealthCare today announced that they have initiated ... the efficacy and safety of VEGF Trap-Eye (aflibercept ophthalmic ... certain eye diseases, in the treatment of Diabetic Macular ...
... Texas, April 7, 2011 Assured Pharmacy (APHY: pinksheets), ... more than 3,000 sufferers of chronic pain, has filed ... to effect a 1-for-180 reverse stock split of the ... reverse stock split in the number of issued and ...
Cached Medicine Technology:Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema 2Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema 3Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema 4Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema 5Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema 6Assured Pharmacy Announces Reverse Stock Split 2Assured Pharmacy Announces Reverse Stock Split 3
Each handle is designed to fit a specific trephine size....
... of German Craftsmanship have ... instrumentation in the world. ... available to you! Only ... Meisterbrief certificate, which requires ...
... Centuries of German ... finest surgical instrumentation in ... makes them available to ... the coveted Meisterbrief certificate, ...
... Ophthalmic Products are constructed of ... lint-free MEROCEL polyvinyl acetal sponge. ... be beneficial to both surgeon ... and yet firm enough to ...
Medicine Products: